Unknown

Dataset Information

0

Fumaric acid esters stimulate astrocytic VEGF expression through HIF-1? and Nrf2.


ABSTRACT: Fumaric acid esters (FAE) are oral analogs of fumarate that have recently been shown to decrease relapse rate and disease progression in multiple sclerosis (MS), prompting to investigate their protective potential in other neurological diseases such as amyotrophic lateral sclerosis (ALS). Despite efficacy in MS, mechanisms of action of FAEs are still largely unknown. FAEs are known to activate the transcription factor Nrf2 and downstream anti-oxidant responses through the succination of Nrf2 inhibitor KEAP1. However, fumarate is also a known inhibitor of prolyl-hydroxylases domain enzymes (PhD), and PhD inhibition might lead to stabilization of the HIF-1? transcription factor under normoxic conditions and subsequent activation of a pseudo hypoxic response. Whether Nrf2 activation is associated with HIF-1? stabilization in response to FAEs in cell types relevant to MS or ALS remains unknown. Here, we show that FAEs elicit HIF-1? accumulation, and VEGF release as its expected consequence, in astrocytes but not in other cell types of the central nervous system. Reporter assays demonstrated that increased astrocytic VEGF release in response to FAEs was dependent upon both HIF-1? and Nrf2 activation. Last, astrocytes of transgenic mice expressing SOD1(G93A), an animal model of ALS, displayed reduced VEGF release in response to FAEs. These studies show that FAEs elicit different signaling pathways in cell types from the central nervous system, in particular a pseudo-hypoxic response in astrocytes. Disease relevant mutations might affect this response.

SUBMITTER: Wiesner D 

PROVIDER: S-EPMC3789659 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature

altmetric image

Publications

Fumaric acid esters stimulate astrocytic VEGF expression through HIF-1α and Nrf2.

Wiesner Diana D   Merdian Irma I   Lewerenz Jan J   Ludolph Albert C AC   Dupuis Luc L   Witting Anke A  

PloS one 20131003 10


Fumaric acid esters (FAE) are oral analogs of fumarate that have recently been shown to decrease relapse rate and disease progression in multiple sclerosis (MS), prompting to investigate their protective potential in other neurological diseases such as amyotrophic lateral sclerosis (ALS). Despite efficacy in MS, mechanisms of action of FAEs are still largely unknown. FAEs are known to activate the transcription factor Nrf2 and downstream anti-oxidant responses through the succination of Nrf2 inh  ...[more]

Similar Datasets

| S-EPMC5683116 | biostudies-literature
| S-EPMC7862084 | biostudies-literature
2018-07-30 | GSE97328 | GEO
| S-EPMC4899530 | biostudies-literature
| S-EPMC5095877 | biostudies-other
| S-EPMC8306801 | biostudies-literature
2016-12-31 | GSE93030 | GEO
| S-EPMC5744071 | biostudies-literature
2015-12-31 | E-MTAB-2406 | biostudies-arrayexpress
| S-EPMC3831500 | biostudies-literature